{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:46:12Z","timestamp":1790721972838,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["ISF Bio-Morasha 1788\/15"],"award-info":[{"award-number":["ISF Bio-Morasha 1788\/15"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["ISF 2295\/19"],"award-info":[{"award-number":["ISF 2295\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>NKX2-2 is a crucial transcription factor that enables specific \u03b2-cell gene expression. Nkx2-2(\u2013\/\u2013) mice manifest with severe neonatal diabetes and changes in \u03b2-cell progenitor fate into ghrelin-producing cells. In humans, recessive NKX2-2 gene mutations have been recently reported as a novel etiology for neonatal diabetes, with only 3 cases known worldwide. This study describes the genetic analysis, distinctive clinical features, the therapeutic challenges, and the unique pathophysiology causing neonatal diabetes in human NKX2-2 dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case Description<\/jats:title>\n                  <jats:p>An infant with very low birth weight (VLBW) and severe neonatal diabetes (NDM) presented with severe obesity and developmental delay already at age 1 year. The challenge of achieving glycemic control in a VLBW infant was unexpectedly met by a regimen of 3 daily doses of long-acting insulin analogues. Sanger sequencing of known NDM genes (such as ABCC8 and EIF2AK3) was followed by whole-exome sequencing that revealed homozygosity of a pathogenic frameshift variant, c.356delG, p.P119fs64*, in the islet cells transcription factor, NKX2-2. To elucidate the cause for the severe obesity, an oral glucose tolerance test was conducted at age 3.5 years and revealed undetectable C-peptide levels with a paradoxically unexpected 30% increase in ghrelin levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Recessive NKX2-2 loss of function causes severe NDM associated with VLBW, childhood obesity, and developmental delay. The severe obesity phenotype is associated with postprandial paradoxical ghrelin secretion, which may be related to human \u03b2-cell fate change to ghrelin-secreting cells, recapitulating the finding in Nkx2-2(\u2013\/\u2013) mice islet cells.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa563","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T18:06:54Z","timestamp":1597946814000},"page":"3486-3495","source":"Crossref","is-referenced-by-count":19,"title":["<i>NKX2-2<\/i> Mutation Causes Congenital Diabetes and Infantile Obesity With Paradoxical Glucose-Induced Ghrelin Secretion"],"prefix":"10.1210","volume":"105","author":[{"given":"Adi","family":"Auerbach","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitay","family":"Cohen","sequence":"additional","affiliation":[{"name":"Hadassah Mt. Scopus, Department of Pediatrics, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Ofek Shlomai","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariella","family":"Weinberg-Shukron","sequence":"additional","affiliation":[{"name":"Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel"},{"name":"Hadassah Medical School, Hebrew University, Jerusalem 9112102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman","family":"Gulsuner","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Claire","family":"King","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Hemi","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Chaim Sheba Medical Center, Ramat-Gan, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrat","family":"Levy-Lahad","sequence":"additional","affiliation":[{"name":"Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel"},{"name":"Hadassah Medical School, Hebrew University, Jerusalem 9112102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsalam","family":"Abulibdeh","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9575-9436","authenticated-orcid":false,"given":"David","family":"Zangen","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Hadassah Hebrew University Medical Center, Jerusalem, Israel"},{"name":"Hadassah Medical School, Hebrew University, Jerusalem 9112102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"2021122106120441300_CIT0001","author":"De Le\u00f3n","year":"2008"},{"issue":"7","key":"2021122106120441300_CIT0002","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00125-011-2094-8","article-title":"Permanent diabetes during the first year of life: multiple gene screening in 54 patients","volume":"54","author":"Russo","year":"2011","journal-title":"Diabetologia."},{"issue":"9","key":"2021122106120441300_CIT0003","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","article-title":"Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy","volume":"54","author":"Hattersley","year":"2005","journal-title":"Diabetes."},{"issue":"12","key":"2021122106120441300_CIT0004","doi-asserted-by":"crossref","first-page":"E2709","DOI":"10.1210\/jc.2014-2494","article-title":"Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons","volume":"99","author":"Carmody","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2021122106120441300_CIT0005","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1242\/dev.125.12.2213","article-title":"Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells","volume":"125","author":"Sussel","year":"1998","journal-title":"Development."},{"issue":"1","key":"2021122106120441300_CIT0006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cmet.2013.11.021","article-title":"Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man","volume":"19","author":"Flanagan","year":"2014","journal-title":"Cell Metab."},{"issue":"9","key":"2021122106120441300_CIT0007","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1073\/pnas.0308604100","article-title":"Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development","volume":"101","author":"Prado","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"2021122106120441300_CIT0008","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.4238\/vol9-3gmr818","article-title":"Comparison of three methods of DNA extraction from peripheral blood mononuclear cells and lung fragments of equines","volume":"9","author":"Santos","year":"2010","journal-title":"Genet Mol Res."},{"issue":"1 Suppl","key":"2021122106120441300_CIT0009","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1177\/1740774510373493","article-title":"Collection and processing of whole blood for transformation of peripheral blood mononuclear cells and extraction of DNA: the Type 1 Diabetes Genetics Consortium","volume":"7","author":"Rosinger","year":"2010","journal-title":"Clin Trials."},{"issue":"6","key":"2021122106120441300_CIT0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/1479-7364-4-6-394","article-title":"KinSNP software for homozygosity mapping of disease genes using SNP microarrays","volume":"4","author":"Amir","year":"2010","journal-title":"Hum Genomics."},{"key":"2021122106120441300_CIT0011","author":"Auerbach","year":"2020"},{"issue":"8","key":"2021122106120441300_CIT0012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-8587(18)30106-2","article-title":"Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study","volume":"6","author":"Bowman","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"Database issue","key":"2021122106120441300_CIT0013","doi-asserted-by":"crossref","first-page":"D749","DOI":"10.1093\/nar\/gkt1196","article-title":"Ensembl 2014","volume":"42","author":"Flicek","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"2021122106120441300_CIT0014","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc."},{"issue":"4","key":"2021122106120441300_CIT0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods."},{"issue":"D1","key":"2021122106120441300_CIT0016","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkw829","article-title":"The International Genome Sample Resource (IGSR): a worldwide collection of genome variation incorporating the 1000 Genomes Project data","volume":"45","author":"Clarke","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2021122106120441300_CIT0017","volume-title":"Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP)","year":"2014"},{"issue":"5","key":"2021122106120441300_CIT0018","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med."},{"key":"2021122106120441300_CIT0019","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-213X-11-52","article-title":"Arx and Nkx2.2 compound deficiency redirects pancreatic alpha- and beta-cell differentiation to a somatostatin\/ghrelin co-expressing cell lineage","volume":"11","author":"Kordowich","year":"2011","journal-title":"BMC Dev Biol."},{"issue":"5","key":"2021122106120441300_CIT0020","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1210\/jc.2004-1582","article-title":"Ghrelin suppression in overweight children: a manifestation of insulin resistance?","volume":"90","author":"Bacha","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122106120441300_CIT0021","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/19315","article-title":"Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling","volume":"398","author":"Briscoe","year":"1999","journal-title":"Nature."},{"issue":"45","key":"2021122106120441300_CIT0022","doi-asserted-by":"crossref","first-page":"31236","DOI":"10.1074\/jbc.M109.048694","article-title":"Cooperative transcriptional regulation of the essential pancreatic islet gene NeuroD1 (beta2) by Nkx2.2 and neurogenin 3","volume":"284","author":"Anderson","year":"2009","journal-title":"J Biol Chem."},{"issue":"8","key":"2021122106120441300_CIT0023","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2337\/db06-1766","article-title":"Nkx2.2 regulates beta-cell function in the mature islet","volume":"56","author":"Doyle","year":"2007","journal-title":"Diabetes."},{"issue":"3","key":"2021122106120441300_CIT0024","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/er.2002-0029","article-title":"Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin","volume":"25","author":"van der Lely","year":"2004","journal-title":"Endocr Rev."},{"issue":"12","key":"2021122106120441300_CIT0025","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/endo.141.12.7920","article-title":"Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression","volume":"141","author":"Kamegai","year":"2000","journal-title":"Endocrinology"},{"key":"2021122106120441300_CIT0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.13385","article-title":"Role of ghrelin in pancreatic development and function","volume":"20","author":"Napolitano","year":"2018","journal-title":"Diabetes Obes Metab."},{"issue":"5","key":"2021122106120441300_CIT0027","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1210\/jc.2013-4010","article-title":"Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents","volume":"99","author":"Prodam","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2021122106120441300_CIT0028","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3748\/wjg.14.1919","article-title":"Changes of ghrelin following oral glucose tolerance test in obese children with insulin resistance","volume":"14","author":"Wang","year":"2008","journal-title":"World J Gastroenterol."},{"issue":"12","key":"2021122106120441300_CIT0029","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1210\/jc.2002-020871","article-title":"High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome","volume":"87","author":"DelParigi","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122106120441300_CIT0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nm0702-643","article-title":"Elevated plasma ghrelin levels in Prader Willi syndrome","volume":"8","author":"Cummings","year":"2002","journal-title":"Nat Med."},{"issue":"11","key":"2021122106120441300_CIT0031","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/a-0746-4014","article-title":"Ghrelin levels in basal conditions and during glucose tolerance test in prediabetic and diabetic patients","volume":"50","author":"Bounias","year":"2018","journal-title":"Horm Metab Res."},{"issue":"2","key":"2021122106120441300_CIT0032","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.peptides.2006.09.024","article-title":"A role for pancreatic polypeptide in feeding and body weight regulation","volume":"28","author":"Kojima","year":"2007","journal-title":"Peptides."},{"key":"2021122106120441300_CIT0033","first-page":"283","article-title":"Neonatal diabetes mellitus.","volume-title":"Pediatric Endocrinology","author":"Sperling","year":"2014","edition":"4"},{"issue":"9","key":"2021122106120441300_CIT0034","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2003-030265","article-title":"Elevated umbilical cord ghrelin concentrations in small for gestational age neonates","volume":"88","author":"Farquhar","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122106120441300_CIT0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1373\/clinchem.2007.095299","article-title":"Ghrelin, leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry?","volume":"54","author":"Chiesa","year":"2008","journal-title":"Clin Chem."},{"issue":"5","key":"2021122106120441300_CIT0036","doi-asserted-by":"crossref","first-page":"E522","DOI":"10.1152\/ajpendo.00420.2011","article-title":"Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance","volume":"302","author":"Ouhilal","year":"2012","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"3","key":"2021122106120441300_CIT0037","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1463-1326.2006.00685.x","article-title":"Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes","volume":"9","author":"Klein","year":"2007","journal-title":"Diabetes Obes Metab."},{"issue":"8","key":"2021122106120441300_CIT0038","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1023\/B:PHAM.0000036926.54824.37","article-title":"The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin","volume":"21","author":"Havelund","year":"2004","journal-title":"Pharm Res."},{"issue":"12","key":"2021122106120441300_CIT0039","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med."},{"issue":"4","key":"2021122106120441300_CIT0040","first-page":"291","article-title":"Treatment of transient neonatal diabetes mellitus with subcutaneous insulin glargine in an extremely low birth weight neonate","volume":"16","author":"Barone","year":"2011","journal-title":"J Pediatr Pharmacol Ther."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa563\/33669095\/dgaa563.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/11\/3486\/41828486\/dgaa563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/11\/3486\/41828486\/dgaa563.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T06:12:56Z","timestamp":1640067176000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/11\/3486\/5895035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,8,20]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa563","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,8,20]]}}}